Jone Trovik Selected Research

Endometrial Neoplasms (Endometrial Cancer)

1/2022	Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study.
3/2021	Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer.
1/2021	Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.
12/2020	Prognostic Value of the Diversity of Nuclear Chromatin Compartments in Gynaecological Carcinomas.
5/2020	Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
1/2020	Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study.
1/2020	High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer.
1/2019	Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study.
1/2019	Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer.
1/2019	Blood steroids are associated with prognosis and fat distribution in endometrial cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jone Trovik Research Topics

Disease

67	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 06/2008
52	Neoplasms (Cancer) 01/2021 - 09/2009
10	Carcinoma (Carcinomatosis) 12/2020 - 06/2008
9	Lymphatic Metastasis 05/2020 - 05/2011
4	Fistula 01/2020 - 02/2007
4	Sarcoma (Soft Tissue Sarcoma) 12/2018 - 02/2014
4	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2016
3	Hyperemesis Gravidarum 06/2022 - 01/2015
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 10/2017
3	Ovarian Neoplasms (Ovarian Cancer) 12/2018 - 09/2009
3	Carcinogenesis 01/2018 - 06/2008
3	Hypoxia (Hypoxemia) 12/2017 - 11/2015
3	Aneuploidy (Aneuploid) 02/2017 - 12/2009
3	Hyperplasia 10/2016 - 03/2013
2	Obesity 01/2021 - 12/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2018
2	Disease Progression 01/2020 - 01/2014
2	Myoma 01/2019 - 02/2014
2	Inflammation (Inflammations) 12/2017 - 11/2015
2	Endometrial Hyperplasia 09/2017 - 03/2013
2	Leiomyosarcoma 03/2017 - 02/2014
2	Breast Neoplasms (Breast Cancer) 10/2016 - 01/2014
1	Fatigue 01/2022
1	Hypesthesia (Numbness) 01/2022
1	Lymphedema (Milroy Disease) 01/2022
1	Urinary Incontinence 01/2020
1	Lymphadenopathy 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Refeeding Syndrome 12/2019
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 12/2019
1	Uterine Hemorrhage (Uterine Bleeding) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Endometrioid Carcinoma 01/2019
1	Endometriosis 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Microsatellite Instability 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2011
14	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2011
10	Messenger RNA (mRNA)IBA 01/2020 - 03/2013
9	Hormones (Hormone)IBA 01/2019 - 11/2013
8	Estrogen ReceptorsIBA 01/2020 - 02/2011
6	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 02/2011
6	Estrogens (Estrogen)FDA Link 01/2019 - 10/2015
5	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 12/2009
5	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2020 - 09/2016
5	StathminIBA 01/2014 - 10/2010
4	ChromatinIBA 12/2020 - 01/2017
3	Tumor Biomarkers (Tumor Markers)IBA 05/2020 - 05/2011
3	Growth Differentiation Factor 15IBA 01/2019 - 07/2011
3	Biological ProductsIBA 01/2018 - 01/2016
3	Androgen Receptors (Androgen Receptor)IBA 12/2017 - 08/2016
3	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2013 - 10/2010
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2020 - 08/2015
2	Edetic Acid (EDTA)FDA Link 01/2019 - 09/2009
2	SteroidsIBA 01/2019 - 12/2017
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2019 - 02/2016
2	human ERBB2 proteinIBA 01/2018 - 10/2017
2	Long Noncoding RNAIBA 01/2018 - 09/2014
2	Transcription Factors (Transcription Factor)IBA 02/2014 - 09/2012
2	TOR Serine-Threonine KinasesIBA 02/2014 - 02/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2014 - 02/2011
2	MTOR InhibitorsIBA 02/2014 - 03/2013
2	Pharmaceutical PreparationsIBA 03/2013 - 06/2008
2	Sp1 Transcription FactorIBA 09/2012 - 01/2012
2	EnzymesIBA 06/2008 - 07/2003
1	AntiemeticsIBA 06/2022
1	Metoclopramide (Reglan)FDA LinkGeneric 06/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	CholesterolIBA 01/2021
1	LipidsIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	AntigensIBA 01/2020
1	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2020
1	Thiamine (Aneurin)FDA Link 12/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2019
1	Contrast MediaIBA 08/2018
1	Protein Isoforms (Isoforms)IBA 06/2018
1	CreatineIBA 04/2018
1	Protons (Proton)IBA 04/2018
1	Choline (Choline Chloride)IBA 04/2018
1	neuromedin UIBA 01/2018
1	Asparaginase (Elspar)FDA Link 01/2018
1	LysophospholipidsIBA 12/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2017

Therapy/Procedure

15	Therapeutics 01/2019 - 06/2008
6	Hysterectomy 01/2022 - 05/2011
5	Curettage 09/2017 - 05/2011
4	Adjuvant Chemotherapy 01/2022 - 02/2011
3	Radiotherapy 03/2021 - 01/2019
1	Aftercare (After-Treatment) 01/2022
1	Salpingo-oophorectomy 01/2022
1	Immunotherapy 01/2020
1	Endometrial Ablation Techniques 01/2019